Conference Reports for NATAP

66th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 13-17 2015 Back

Cost-effectiveness of Combination Daclatasvir-Sofosbuvirfor Genotype 3 Chronic Hepatitis C Infection in the United States       Reported by Jules Levin AASLD 2015 Nov 13-17 San Francisco   Catherine Saint-Laurent Thibault,1DivyaMoorjaney,2Michael L. Ganz,2Bruce Sill,3ShaliniHede,3Yong Yuan,3AnupamaKalsekar,3Boris Gorsh3 1Evidera, Montreal, QC, Canada; 2Evidera, Lexington, MA, USA; 3Bristol-Myers Squibb Company, Plainsboro, NJ, USA